I
Invert
We build software to make biomanufacturing scaleable
About Invert
InvertBio is a pioneering startup focused on revolutionizing the field of biomanufacturing. The company operates in the biotechnology sector, aiming to transform how physical inputs—materials used in manufacturing—are produced. By leveraging biological processes, InvertBio seeks to address critical global challenges such as climate change, poverty, and advancements in material sciences.
The primary clients of InvertBio include industries that rely heavily on physical inputs, such as manufacturing, agriculture, and pharmaceuticals. These clients benefit from more sustainable and efficient production methods that reduce environmental impact and costs.
InvertBio's business model revolves around biomanufacturing, which uses biological systems to produce materials and chemicals. This approach is not only more sustainable but also scalable, meaning it can be expanded to meet increasing demand. The company generates revenue by offering its biomanufacturing technology and services to various industries, enabling them to produce their required materials more efficiently and sustainably.
The market InvertBio operates in is vast and growing, given the increasing global focus on sustainability and reducing carbon footprints. By providing a viable alternative to traditional manufacturing processes, InvertBio positions itself as a key player in the transition towards greener industrial practices.
In summary, InvertBio is at the forefront of biomanufacturing, serving industries that require sustainable production methods. The company makes money by offering its innovative technology and services, which help clients produce materials more efficiently and with less environmental impact.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jul 2024 | $20M | $81M | Undisclosed | ↗ |
| SEED✓Equity / VC | Jul 2022 | $125K | $500K | Y Combinator | — |
Growth signals
Latest recorded traffic for Invert is 7.8K monthly website visits, up 100% over the last three months. Invert's team declined 8.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Other known investors5 additional known investors
ACME Capital
Cathexis ventures
Giant Ventures
Positive Sum- SGStef van Grieken
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Invert on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Invert’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








